<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-topic" /><meta name="keywords" content="Antifungal drugs; Fungal infections; Thrush see Candidiasis; Candidosis see Candidiasis; Candidiasis; Infections: fungal; Aspergillosis; Voriconazole; Amphotericin: systemic; Caspofungin; Itraconazole; Posaconazole; Candidiasis: oropharyngeal; Fungal infections: oral; Fluconazole; Itraconazole; Candidiasis: systemic; Echinocandin antifungals; Voriconazole; Flucytosine; Cryptococcosis; Meningitis: cryptococcal; Amphotericin: systemic; Flucytosine; Fluconazole; Histoplasmosis; Itraconazole; Amphotericin: systemic; Dermatophyte infections; Tinea infections; Onychomycosis see Fungal infections; Infections: nail, fungal; Itraconazole; Terbinafine; Griseofulvin; Pityriasis versicolor; Fluconazole; Infections: nail, fungal; Fluconazole; Itraconazole; Micafungin; Amphotericin: systemic; Caspofungin" /><meta name="IX" content="Antifungal drugs; Fungal infections; Candidiasis; Infections: fungal; Aspergillosis; Voriconazole; Amphotericin: systemic; Caspofungin; Itraconazole; Posaconazole; Candidiasis: oropharyngeal; Fungal infections: oral; Fluconazole; Itraconazole; Candidiasis: systemic; Echinocandin antifungals; Voriconazole; Flucytosine; Cryptococcosis; Meningitis: cryptococcal; Amphotericin: systemic; Flucytosine; Fluconazole; Histoplasmosis; Itraconazole; Amphotericin: systemic; Dermatophyte infections; Tinea infections; Infections: nail, fungal; Itraconazole; Terbinafine; Griseofulvin; Pityriasis versicolor; Fluconazole; Infections: nail, fungal; Fluconazole; Itraconazole; Micafungin; Amphotericin: systemic; Caspofungin" /><meta name="IXN" content="Thrush see Candidiasis; Candidosis see Candidiasis; Onychomycosis see Fungal infections" /><title>Treatment of fungal infections: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3693-treatment-of-fungal-infections.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3693-treatment-of-fungal-infections.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3693-treatment-of-fungal-infections.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP3253-infections.htm">5 Infections</a> &gt; <a href="PHP3692-antifungal-drugs.htm">5.2 Antifungal drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3692-antifungal-drugs.htm" title="Previous: 5.2 Antifungal drugs">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3698-triazole-antifungals.htm" title="Next: 5.2.1 Triazole antifungals">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>Treatment of fungal infections</h1><?highlighter on?><div id="pC" class="jN"><p>The systemic treatment of common fungal infections is outlined below; specialist treatment is required in most forms of systemic or disseminated fungal infections. For local treatment of fungal infections, <a href="PHP4822-vaginal-and-vulval-infections.htm">see section 7.2.2</a> (genital), <a title="BNF:sub-section: Bladder instillations and urological surgery" href="PHP5124-bladder-instillations-and-urological-surgery.htm">section 7.4.4</a> (bladder), <a title="BNF:sub-section: Antifungals" href="PHP6851-antifungals.htm">section 11.3.2</a> (eye), <a title="BNF:monograph-family: Anti-infective preparations" href="PHP7227-anti-infective-preparations.htm">section 12.1.1</a> (ear), <a title="BNF:monograph-family: Oropharyngeal fungal infections" href="PHP7381-oropharyngeal-fungal-infections.htm">section 12.3.2</a> (oropharynx), and <a title="BNF:sub-section: Antifungal preparations" href="PHP8003-antifungal-preparations.htm">section 13.10.2</a> (skin).</p><div><h2>Aspergillosis</h2><p>Aspergillosis most commonly affects the respiratory tract but in severely immunocompromised patients, invasive forms can affect the heart, brain, and skin. <strong>Voriconazole</strong> (<a title="BNF:monograph: VORICONAZOLE" href="PHP3709-voriconazole.htm">section 5.2.1</a>) is the treatment of choice for aspergillosis; <strong>liposomal amphotericin</strong> (<a title="BNF:sub-section: Polyene antifungals" href="PHP3716-polyene-antifungals.htm">section 5.2.3</a>) is an alternative first-line treatment when voriconazole cannot be used. <strong>Caspofungin</strong> (<a title="BNF:sub-section: Echinocandin antifungals" href="PHP3725-echinocandin-antifungals.htm">section 5.2.4</a>), <strong>itraconazole</strong> (<a title="BNF:monograph: ITRACONAZOLE" href="PHP3702-itraconazole.htm">section 5.2.1</a>), or <strong>posaconazole</strong> (<a title="BNF:monograph: POSACONAZOLE" href="PHP3707-posaconazole.htm">section 5.2.1</a>) can be used in patients who are refractory to, or intolerant of voriconazole and liposomal amphotericin. Itraconazole is also used for the treatment of chronic pulmonary aspergillosis or as an adjunct in the treatment of allergic bronchopulmonary aspergillosis [unlicensed indication].</p></div><div id="PHP3694"><h2>Candidiasis</h2><p>Many superficial candidal infections including infections of the skin (<a title="target-block: candidiasis" href="PHP8003-antifungal-preparations.htm#PHP8007">section 13.10.2</a>) are treated locally; widespread or intractable infection requires systemic antifungal treatment. Vaginal candidiasis (<a href="PHP4822-vaginal-and-vulval-infections.htm">section 7.2.2</a>) may be treated with locally acting antifungals or with <strong>fluconazole</strong> (<a title="BNF:monograph: FLUCONAZOLE" href="PHP3699-fluconazole.htm">section 5.2.1</a>) given by mouth; for resistant organisms, <strong>itraconazole</strong> (<a title="BNF:monograph: ITRACONAZOLE" href="PHP3702-itraconazole.htm">section 5.2.1</a>) can be given by mouth.</p><p><em>Oropharyngeal candidiasis</em> generally responds to topical therapy (<a href="PHP7380-oropharyngeal-anti-infective-drugs.htm">section 12.3.2</a>); fluconazole is given by mouth for unresponsive infections; it is effective and is reliably absorbed. Itraconazole may be used for infections that do not respond to fluconazole. Topical therapy may not be adequate in immunocompromised patients and an oral triazole antifungal is preferred.</p>  <p>For <em>invasive or disseminated candidiasis</em>, an <strong>echinocandin</strong> (<a title="BNF:sub-section: Echinocandin antifungals" href="PHP3725-echinocandin-antifungals.htm">section 5.2.4</a>) can be used. <strong>Fluconazole</strong> (<a title="BNF:monograph: FLUCONAZOLE" href="PHP3699-fluconazole.htm">section 5.2.1</a>) is an alternative for <em>Candida albicans</em> infection in clinically stable patients who have not received an azole antifungal recently. <strong>Amphotericin</strong> (<a title="BNF:sub-section: Polyene antifungals" href="PHP3716-polyene-antifungals.htm">section 5.2.3</a>) is an alternative when an echinocandin or fluconazole cannot be used, however, amphotericin should be considered for the initial treatment of CNS candidiasis. <strong>Voriconazole</strong> (<a title="BNF:monograph: VORICONAZOLE" href="PHP3709-voriconazole.htm">section 5.2.1</a>) can be used for infections caused by fluconazole-resistant <em>Candida</em> spp. when oral therapy is required, or in patients intolerant of amphotericin or an echinocandin. In refractory cases, <strong>flucytosine</strong> (<a title="BNF:sub-section: Other antifungals" href="PHP3732-other-antifungals.htm">section 5.2.5</a>) can be used with intravenous amphotericin.</p></div><div id="PHP3695"><h2>Cryptococcosis</h2><p>Cryptococcosis is uncommon but infection in the immunocompromised, especially in HIV-positive patients, can be life-threatening; cryptococcal meningitis is the most common form of fungal meningitis. The treatment of choice in cryptococcal meningitis is <strong>amphotericin</strong> (<a title="BNF:monograph: AMPHOTERICIN" href="PHP3717-amphotericin.htm">section 5.2.3</a>) by intravenous infusion and <strong>flucytosine</strong> (<a title="BNF:monograph: FLUCYTOSINE" href="PHP3733-flucytosine.htm">section 5.2.5</a>) by intravenous infusion for 2 weeks, followed by <strong>fluconazole</strong> (<a title="BNF:monograph: FLUCONAZOLE" href="PHP3699-fluconazole.htm">section 5.2.1</a>) by mouth for 8 weeks or until cultures are negative. In cryptococcosis, <strong>fluconazole</strong> is sometimes given alone as an alternative in HIV-positive patients with mild, localised infections or in those who cannot tolerate amphotericin. Following successful treatment, fluconazole can be used for prophylaxis against relapse until immunity recovers.</p></div><div><h2>Histoplasmosis</h2><p>Histoplasmosis is rare in temperate climates; it can be life-threatening, particularly in HIV-infected persons. <strong>Itraconazole</strong> (<a title="BNF:monograph: ITRACONAZOLE" href="PHP3702-itraconazole.htm">section 5.2.1</a>) can be used for the treatment of immunocompetent patients with indolent non-meningeal infection, including chronic pulmonary histoplasmosis. <strong>Amphotericin</strong> (<a title="BNF:sub-section: Polyene antifungals" href="PHP3716-polyene-antifungals.htm">section 5.2.3</a>) by intravenous infusion is preferred in patients with fulminant or severe infections. Following successful treatment, itraconazole can be used for prophylaxis against relapse until immunity recovers.</p></div><div id="PHP3696"><h2>Skin and nail infections</h2><p>Mild localised fungal infections of the skin (including tinea corporis, tinea cruris, and tinea pedis) respond to topical therapy (<a title="sub-section: Antifungal preparations" href="PHP8003-antifungal-preparations.htm">section 13.10.2</a>). Systemic therapy is appropriate if topical therapy fails, if many areas are affected, or if the site of infection is difficult to treat such as in infections of the nails (onychomycosis) and of the scalp (tinea capitis). Oral <a title="BNF:sub-section: Imidazole antifungals" href="PHP3711-imidazole-antifungals.htm">imidazole</a> or <a title="BNF:sub-section: Triazole antifungals" href="PHP3698-triazole-antifungals.htm">triazole antifungals</a> (particularly <a title="BNF:monograph: ITRACONAZOLE" href="PHP3702-itraconazole.htm"><strong>itraconazole</strong></a>) and <a title="BNF:monograph: TERBINAFINE" href="PHP3739-terbinafine.htm"><strong>terbinafine</strong></a> are used more frequently than griseofulvin because they have a broader spectrum of activity and require a shorter duration of treatment.</p><p><em>Tinea capitis</em> is treated systemically; additional topical application of an antifungal (<a title="sub-section: Antifungal preparations" href="PHP8003-antifungal-preparations.htm">section 13.10.2</a>) may reduce transmission. <strong>Griseofulvin</strong> (<a title="BNF:monograph: GRISEOFULVIN" href="PHP3736-griseofulvin.htm">section 5.2.5</a>) is used for tinea capitis in adults and children; it is effective against infections caused by <em>Trichophyton tonsurans</em> and <em>Microsporum</em> spp. <strong>Terbinafine</strong> (<a title="BNF:monograph: TERBINAFINE" href="PHP3739-terbinafine.htm">section 5.2.5</a>) is used for tinea capitis caused by <em>T. tonsurans</em> [unlicensed indication]. The role of terbinafine in the management of <em>Microsporum</em> infections is uncertain.</p><p><em>Pityriasis versicolor</em> (<a title="target-block: Pityriasis versicolor" href="PHP8003-antifungal-preparations.htm#PHP8006">section 13.10.2</a>) may be treated with <strong>itraconazole</strong> (<a title="BNF:monograph: ITRACONAZOLE" href="PHP3702-itraconazole.htm">section 5.2.1</a>) by mouth if topical therapy is ineffective; <strong>fluconazole</strong> (<a title="BNF:monograph: FLUCONAZOLE" href="PHP3699-fluconazole.htm">section 5.2.1</a>) by mouth is an alternative. Oral <strong>terbinafine </strong>is <strong>not </strong>effective for pityriasis versicolor.</p><p>Antifungal treatment may not be necessary in asymptomatic patients with tinea infection of the nails. If treatment is necessary, a systemic antifungal is more effective than topical therapy. <strong>Terbinafine</strong> (<a title="BNF:monograph: TERBINAFINE" href="PHP3739-terbinafine.htm">section 5.2.5</a>) and <strong>itraconazole</strong> (<a title="BNF:monograph: ITRACONAZOLE" href="PHP3702-itraconazole.htm">section 5.2.1</a>) have largely replaced griseofulvin for the systemic treatment of <em>onychomycosis</em>, particularly of the toenail; terbinafine is considered to be the drug of choice. Itraconazole can be administered as intermittent ‘pulse’ therapy. For the role of topical antifungals in the treatment of onychomycosis, see <a title="sub-section: Antifungal preparations" href="PHP8003-antifungal-preparations.htm#PHP8005">section 13.10.2</a>.</p></div><div id="PHP3697"><h2>Immunocompromised patients</h2><p>Immunocompromised patients are at particular risk of fungal infections and may receive antifungal drugs prophylactically; oral triazole antifungals are the drugs of choice for prophylaxis. <strong>Fluconazole</strong> (<a title="BNF:monograph: FLUCONAZOLE" href="PHP3699-fluconazole.htm">section 5.2.1</a>) is more reliably absorbed than <strong>itraconazole</strong> (<a title="BNF:monograph: ITRACONAZOLE" href="PHP3702-itraconazole.htm">section 5.2.1</a>), but fluconazole is not effective against <em>Aspergillus</em> spp. Itraconazole is preferred in patients at risk of invasive aspergillosis. <strong>Posaconazole</strong> (<a title="BNF:monograph: POSACONAZOLE" href="PHP3707-posaconazole.htm">section 5.2.1</a>) can be used for prophylaxis in patients who are undergoing haematopoietic stem cell transplantation or receiving chemotherapy for acute myeloid leukaemia and myelodysplastic syndrome, if they are intolerant of fluconazole or itraconazole. <strong>Micafungin</strong> (<a title="BNF:monograph: MICAFUNGIN" href="PHP3730-micafungin.htm">section 5.2.4</a>) can be used for prophylaxis of candidiasis in patients undergoing haematopoietic stem cell transplantation when fluconazole, itraconazole or posaconazole cannot be used.</p><p><strong>Amphotericin</strong> (<a title="BNF:monograph: AMPHOTERICIN" href="PHP3717-amphotericin.htm">section 5.2.3</a>) by intravenous infusion or <strong>caspofungin</strong> (<a title="BNF:monograph: CASPOFUNGIN" href="PHP3728-caspofungin.htm">section 5.2.4</a>) is used for the empirical <em>treatment</em> of serious fungal infections; caspofungin is not effective against fungal infections of the CNS.</p></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3692-antifungal-drugs.htm">Previous: 5.2 Antifungal drugs</a> | <a class="top" href="PHP3693-treatment-of-fungal-infections.htm#">Top</a> | <a accesskey="]" href="PHP3698-triazole-antifungals.htm">Next: 5.2.1 Triazole antifungals</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>